South Tulsa Pathology Laboratory, Inc. - Page 7




                                        - 7 -                                         
               A.   Spinoff of Clinpath, Inc.                                         
               On October 5, 1993, petitioner formed Clinpath, Inc.                   
          (Clinpath), an Oklahoma general business corporation.  Pursuant             
          to a subscription agreement between petitioner and Clinpath,                
          dated October 6, 1993, petitioner agreed to purchase 14,399                 
          shares of the common stock of Clinpath, representing 100 percent            
          of the issued shares of Clinpath.                                           
               On October 29, 1993, petitioner and its shareholders entered           
          into a reorganization agreement in which they agreed, among other           
          things, that:  (1) Petitioner shall contribute all of its                   
          clinical laboratory assets to Clinpath in exchange for 14,399               
          shares of Clinpath stock issued to petitioner; and (2) after the            
          exchange of petitioner’s clinical laboratory assets for Clinpath            
          stock, petitioner promptly shall distribute all of the Clinpath             
          stock to petitioner’s shareholders in proportion to their                   
          ownership of stock in petitioner. Also, on October 29,                      
          petitioner transferred the clinical laboratory assets, including            
          goodwill, to Clinpath, and Clinpath transferred 14,399 shares of            
          its common stock to petitioner.  Petitioner’s adjusted basis in             
          the Clinpath stock it received equaled $105,015, its adjusted               
          basis in the clinical laboratory assets it transferred to                   
          Clinpath in exchange for the stock.                                         
               On October 30, 1993, petitioner distributed 100 percent of             
          the Clinpath stock to petitioner’s shareholders in proportion to            






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  Next

Last modified: May 25, 2011